To facilitate biosimilar uptake, several mechanisms aimed at reducing the acquisition cost of biosim...
Read moreHTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedent...
Read moreTo facilitate biosimilar uptake, several mechanisms encouraging biosimilar uptake have been implemen...
Read moreA survey of employees within pricing and market access n pharma and biotech companies.
Read moreICER’s Health Technology Assessments review process is an assessment undertaken by one of three ap...
Read moreRemap Consulting are ideally placed to support the completion of price certificates ready for legali...
Read moreGVD is a core document, which may be considered the “heart” of the pharmaceutical product’s pa...
Read moreHow has the data available within NCRAS been utilized within the CDF overseen by NICE, in partnershi...
Read moreWithout a doubt, the impact of COVID-19 will influence all sectors, including the future of market a...
Read moreIRP is a pricing mechanism where the price of a drug in one country is set or adjusted in relation t...
Read more